Dr. Kevin Gene Drew, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3740 Edison Lakes Pkwy, Mishawaka, IN 46545 Phone: 574-252-4150 Fax: 574-252-4159 |
Dr. Roger Klauer, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 60101 Bodnar Blvd, Suite 100b, Mishawaka, IN 46544 Phone: 574-335-8500 Fax: 574-335-0794 |
Dr. Kathryn L Park, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 301 E Day Rd, Mishawaka, IN 46545 Phone: 574-237-9340 Fax: 574-239-1474 |
Arman Borhan, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3212 Hickory Rd, Suite B, Mishawaka, IN 46545 Phone: 574-251-0498 Fax: 574-251-0068 |
Dr. Stephen Ralph Ribaudo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 229 Red Coach Dr, Suite 102, Mishawaka, IN 46545 Phone: 574-252-5852 Fax: 574-252-5862 |
Abhishek Das, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5314 Lincolnway E, Mishawaka, IN 46544 Phone: 574-256-9032 Fax: 574-256-9049 |
News Archive
The incarcerated population - both those currently in prison and those who have been released - are more susceptible to heart disease than the rest of the country's population. And what we know about the factors that play into this is extremely limited, according to researchers.
Children's Hospital Colorado has been approved for a $50,000 funding award by the Patient-Centered Outcomes Research Institute to support a project on developing effective interventions to achieve a healthy weight among Hispanic children ages 0-5.
Spacelabs Healthcare has received clearance under Section 510(k) from the U.S. Food and Drug Administration to market Arkon, a high-performance anesthesia delivery system designed from the anesthesiologist's perspective.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $11.25 per share.
› Verified 5 days ago